The Immunocytochemical Detection of P53 Protein In Cytological Specimens: Technical Considerations
- 1 April 1994
- journal article
- Published by Wiley in Cytopathology
- Vol. 5 (2) , 76-81
- https://doi.org/10.1111/j.1365-2303.1994.tb00530.x
Abstract
The p53 gene encodes a 393 amino acid nuclear phosphoprotein that appears to act as a cell cycle checkpoint, possibly by transactivating other target genes. Abnormalities of the p53 gene are common in a wide range of human tumours and are associated in many cases with immunologically detectable p53 protein. Detection of p53 immunoreactivity is uncommon in normal cells, but is frequently seen in neoplasia. Here we define the optimum conditions for the detection of p53 immunoreactivity in cytological material, including fixation and storage. Immersion in acetone-methanol for 10 min is optimal, and after air drying, smears or cytospin preparations can be stored at -70 degrees C for at least 6 months. We describe the range of controls necessary, including the use of positive control cell lines with known mutations of the p53 gene and defined abnormalities of p53 protein. Negative controls should include cell lines (or strains) with no p53 abnormality as well as the conventional negative immunological controls. It is only with these technical caveats and controls that p53 immunoreactivity can be performed reliably on cytological specimens.Keywords
This publication has 22 references indexed in Scilit:
- A death in the life of p53Nature, 1993
- Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cellsCell, 1992
- Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.Proceedings of the National Academy of Sciences, 1992
- Wild-type p53 activates transcription in vitroNature, 1992
- Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.Proceedings of the National Academy of Sciences, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- Identification of p53 as a Sequence-Specific DNA-Binding ProteinScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989